Annual Report 2003 - Nobel Biocare Corporate

NOBEL BIOCARE ANNUAL REPORT 200311market, followed by the US and Asia.The highest growth rate is beingseen in the US, which is a youngerand less penetrated market with aslightly larger number of edentulousor partly edentulous patients.Implants represent 50 percent ofsales, abutments 35–40 percent andinstruments 10–15 percent.In addition to demography, themarket may be driven by an improvedglobal economy in the coming years.Crown and bridge marketThe crown and bridge market isestimated to about EUR 2.4 billioncovering around 110 million units.Globally, single units stand for 65percent of the total volume, whilebridges account for 35 percent.Bridges are most common inGermany and the rest of Europe,while in the US, approximately 85percent of the volume comes fromsingle units.The governing market trends arethe development of new all-ceramicmaterials for improved esthetics andthe outsourcing of parts of the productionfrom the laboratories toindustrial actors.All-ceramic materials account for15 percent of the volume, comparedto PFM (porcelain fused to metal)materials totalling up to 85 percent.The highest penetration for allceramicmaterials (20%) has beenrecorded in the US.The outsourcing trend resultsfrom the use of CAD/CAM systemsallowing the industrialized productionof the inner part, or coping, of thecrown. Of the all-ceramic units, eightpercent is produced by differentCAD/CAM systems.Players on the dental marketThe total dental market is somewhatfragmented. Nobel Biocare is theclear market leader with a marketshare of 32 percent. Nobel Biocareholds the leading position on theregional markets in North America,Europe and Asia as well as in mostindividual countries such as the USand Japan.The main competitors on theimplant market include the Swiss companyStraumann, and the US companiesBiomet, Centerpulse Dental(acquired by US Zimmer in 2003)and Dentsply. In total, the five companiescontrol almost 85 percent ofthe market.Nobel Biocare not only ranks themarket leader in size. The companyalso has an innovative approach and afully integrated offer, covering bothcrowns and bridges and implants. Thisgives Nobel Biocare a unique positionwithin the entire dental industryaddressing dentists, specialists anddental laboratories with one commonoffer.Within the All-Ceramic prostheticssegment, Nobel Biocare holds amarket share of 6 percent. In Europe,Nobel Biocare’s market share is14 percent, while in North Americait is 7 percent. In the CAD/CAMsector, Nobel Biocare is the marketleader with more than 4 million individualizedunits produced.